Summary & Overview
HCPCS Level II G2068: Buprenorphine Weekly Medication-Assisted Treatment Bundle
HCPCS Level II code G2068 designates a weekly bundle for medication‑assisted treatment (MAT) using oral buprenorphine delivered by Medicare‑enrolled opioid treatment programs. The bundle covers dispensing and/or administration of buprenorphine plus integrated services such as substance use counseling, individual and group therapy, and toxicology testing when performed. This code matters nationally as MAT with buprenorphine is a core component of the public health response to opioid use disorder and influences access, care coordination, and payment for comprehensive weekly treatment packages.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service represented by the code, expected sites of service, and the payer landscape. The publication also summarizes benchmarks and reimbursement patterns, recent policy updates affecting bundled MAT payments, and clinical context for implementation in outpatient opioid treatment settings. Where specific data points are not provided in the source input, the text notes that data is not available in the input.
Billing Code Overview
HCPCS Level II code G2068 represents a weekly bundled service for medication-assisted treatment with oral buprenorphine provided by a Medicare-enrolled opioid treatment program. The bundle includes dispensing and/or administration of buprenorphine, substance use counseling, individual and group therapy, and toxicology testing if performed.
Service Type: Medication-assisted treatment bundle (buprenorphine), behavioral health and substance use disorder services
Typical Site of Service: Opioid treatment program or outpatient behavioral health clinic enrolled in Medicare
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient with moderate-to-severe opioid use disorder presents to a Medicare-enrolled opioid treatment program (OTP) for a weekly bundled medication-assisted treatment (MAT) visit using oral buprenorphine. The OTP performs medication dispensing/administration, provides individual counseling, offers group therapy sessions during the week, and completes point-of-care urine toxicology testing as indicated. The clinical workflow begins with nurse intake (vital signs, medication reconciliation), clinician evaluation for buprenorphine dosing and safety checks, on-site dispensing of the weekly oral buprenorphine supply, brief individual counseling focused on adherence and relapse prevention, enrollment or participation in a group therapy session, and collection/processing of a urine sample for toxicology if clinically indicated. Documentation includes medication administration/dispensing records, counseling and therapy notes, consent for treatment, toxicology results, care coordination notes, and treatment progress tracking. The service typically occurs in an outpatient opioid treatment program setting with interdisciplinary staff including physicians, nurse practitioners, licensed clinical social workers, counselors, and nursing staff.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | General billing indicator (not a CMS modifier in common use) | Use only if payer-specific systems require a placeholder code; verify payer guidance before use. |